Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: enzastaurin|DRUG: placebo|DRUG: fulvestrant
Sponsor: Eli Lilly and Company